Mixed Lineage Acute Leukemia
3 clinical trials · Condition
◉ Watch Mixed Lineage Acute Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (NCT04065399) | Syndax Pharmaceuticals | 2019-11-05 |
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336) | Kura Oncology, Inc. | 2019-09-12 |
| Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies (NCT02419755) | St. Jude Children's Research Hospital | 2015-04-14 |
Track Mixed Lineage Acute Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.